Then, when you look at the STEP 4 trial, which randomly assigned participants receiving semaglutide 2.4 mg at 1 year to continue the drug or receive placebo, most of the patients who stopped semaglutide regained their weight
Youll need to complete an online assessment to request Wegovy, so our doctors can check your medical history and BMI first
The therapy, indicated for adults with obesity or those who are overweight with weight-related conditions, will be available starting at $149 per month for the lowest dose under Ros cash-pay model, excluding membership fees
Sustainable Weight Loss & Body Composition Changes Microdosing may help maintain weight loss achieved on full-dose protocols, allowing long-term metabolic benefits while minimizing dose-related discomfort
Discuss a long-term management plan with your prescriber before starting
What the Research Actually Shows The STEP 4 trial the landmark study on stopping semaglutide is the most definitive data we have